Open | - |
Close | - |
Volume / Avg. | 0 / 136.681K |
Day Range | - - - |
52 Wk Range | 36.540 - 70.500 |
Market Cap | $1.425B |
P/E Ratio | 79.553 |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 69 |
Short Interest | 1.5% |
Days to Cover | 2.88 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of ANI Pharmaceuticals (NASDAQ: ANIP) through any online brokerage.
Other companies in ANI Pharmaceuticals’s space includes: Supernus Pharmaceuticals (NASDAQ:SUPN), Verona Pharma (NASDAQ:VRNA), Tarsus Pharmaceuticals (NASDAQ:TARS), Neumora Therapeutics (NASDAQ:NMRA) and Ocular Therapeutix (NASDAQ:OCUL).
The latest price target for ANI Pharmaceuticals (NASDAQ: ANIP) was reported by Capital One on Friday, March 15, 2024. The analyst firm set a price target for 0.00 expecting ANIP to fall to within 12 months (a possible -100.00% downside). 16 analyst firms have reported ratings in the last year.
The stock price for ANI Pharmaceuticals (NASDAQ: ANIP) is $67.62 last updated March 18, 2024 at 4:00 PM EDT.
There are no upcoming dividends for ANI Pharmaceuticals.
ANI Pharmaceuticals’s Q1 earnings are confirmed for Monday, May 6, 2024.
There is no upcoming split for ANI Pharmaceuticals.
ANI Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.